Powered by

-Mithra - Full Estetrol (E4) Program Update Provided at Scientific Advisory Board Meetings

Nov 20, 2018 - ENP Newswire

Liege - Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, announces that it held two scientific advisory board (SAB) meetings in New Orleans (LA) at the end of October to discuss the progressin the development plans for Estelle and Donesta, Mithra's key programs for contraception and menopause.

The SABs, composed of American and Canadian experts in these fields, provided constructive feedback on the recently completed EU/Russia phase III trials for Estelle. Guidance...